Copyright
©The Author(s) 2015.
World J Gastroenterol. Aug 21, 2015; 21(31): 9394-9402
Published online Aug 21, 2015. doi: 10.3748/wjg.v21.i31.9394
Published online Aug 21, 2015. doi: 10.3748/wjg.v21.i31.9394
Table 1 Basic information on the study population
| Factors | n (%) |
| Age (yr), mean (SD) | 51.8 (12.4) |
| Age > 65 yr | 102 (15.1) |
| Male | 502 (79.2) |
| ICG R15 | |
| < 10% | 545 (86.8) |
| 10%-20% | 69 (10.9) |
| 20%-30% | 8 (1.3) |
| 30%-40% | 6 (0.9) |
| > 40% | 6 (0.9) |
| Hepatitis serology | |
| Hepatitis B | 452 (71.3) |
| Hepatitis C | 34 (5.4) |
| Hepatitis B and C | 25 (3.9) |
| Negative or not determined | 123 (19.4) |
| Cirrhosis | 479 (75.5) |
| Portal vein hypertention | 78 (12.3) |
- Citation: Wang XQ, Liu Z, Lv WP, Luo Y, Yang GY, Li CH, Meng XF, Liu Y, Xu KS, Dong JH. Safety validation of decision trees for hepatocellular carcinoma. World J Gastroenterol 2015; 21(31): 9394-9402
- URL: https://www.wjgnet.com/1007-9327/full/v21/i31/9394.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i31.9394